Embody NAD+ review

A clear introductory rate, followed by a subscription

Embody’s dedicated NAD+ page lists compounded injection and nasal options at $49 for the first month and $99 per month afterward. ^[1] That is a concrete price sequence, not an ongoing $49 program. A reader comparing services should separate the first payment from the cost of continuing. The introductory saving is meaningful only if the supplied preparation, clinical purpose and subscription terms fit. It should not carry more weight than a commitment the buyer would hesitate to accept at the regular rate.

Two formats do not mean equal evidence

The page offers both an injectable preparation and a nasal spray. ^[1] The choice may matter for preference and logistics, but it is not a demonstration that the formats provide the same exposure or clinical benefit. Ask the clinician to identify the actual prescribed route, amount and intended outcome. A statement that NAD+ participates in cellular metabolism does not settle whether the proposed product improves fatigue, cognition or healthy lifespan. Route selection is a clinical discussion as well as a convenience decision.

The absorption comparison asks for more evidence

Embody presents a comparison graphic favoring injections over supplements, with claims about absorption and speed. ^[1] Our assessment is that those claims should not be used as a substitute for an appropriate clinical outcome trial. An exposure claim, even if accurate for a preparation, cannot by itself show that a reader will feel better. A broad supplement category also contains different molecules and formulations. Before paying more for a seemingly superior route, identify the human evidence for the exact result and intervention under consideration.

For the clinical distinction, read oral injected infused nad.

The refund policy is substantially less flexible

Embody’s policy says subscription payments are final at purchase, including single-month and bundled plans; ordinary non-use does not produce a refund. A provider-initiated medical disqualification is a stated exception for the unused portion after rendered services are deducted. ^[2] That is a material condition for an elective program. Treat payment as a commitment to the bundle rather than a refundable reservation for one medication shipment. Anyone uncertain about the service should clarify the basic clinical and financial questions before submitting payment or intake.

Canceling future billing requires advance notice

The policy requires a cancellation request at least 72 hours before the next billing date to stop that charge. Cancellation affects future billing rather than refunding the paid term. ^[2] A cancel-anytime headline can therefore coexist with a deadline that arrives before renewal. For practical comparison, record both the billing date and the effective cutoff. If considering more than one month, ask which term is being purchased and whether the cancellation request merely prevents the next term rather than shortening the current one.

Named pharmacies help frame the right question

The dedicated page identifies a provider network and lists pharmacy partners, while preserving clinician discretion to prescribe. ^[1] That is more useful than a vague suggestion that the platform itself manufactures the medicine. It does not mean every patient receives a product from every listed pharmacy. Ask which pharmacy will fill the particular prescription, what formulation it supplies and who addresses delivery or preparation questions. A named network is a starting point for clarification; the actual prescription and supplied instructions remain the important purchase details.

For a separate service comparison, see CoreAge Rx versus AgelessRx NAD+; compare the actual treatment and terms rather than assuming the services are interchangeable.

Our verdict favors clarity over the discount

Embody can be considered by a reader who specifically wants an online NAD+ assessment and understands that the subscription is financially restrictive. Its clearest merits are the visible introductory-to-renewal sequence and identifiable routes. Its weakest fit is the shopper seeking a low-risk experiment with easy refunds or expecting a route graphic to establish rejuvenation. We would decide on the clinical rationale and full agreement first, then count the introductory saving. The price is easy to read; the obligations need the same attention.

Understanding the cost

$49 for the first month, then $99/month for listed NAD+ options. Payments are generally final; a narrow medical-disqualification exception and a 72-hour cancellation cutoff apply. ^{[1] [2]}